Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine

7 Dec 2016

Abstract excerpt

// Costantine Albany 1 , Mary P. Hever-Jardine 2 , Katherine M. von Herrmann 2 , Christina Y. Yim 2 , Janice Tam 2 , Joshua M. Warzecha 2 , Leah Shin 2 , Sarah E. Bock 2 , Brian S. Curran 2 , Aneeq S. Chaudhry 2 , Fred Kim 2 , George E. Sandusky 5 , Pietro Taverna 3 , Sarah J. Freemantle 4 , Brock C. Christensen 6 , Lawrence H. Einhorn 1 , Michael J. Spinella 4 1 Division of Hematology/Oncology, Melvin and Bren...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomal and Genetic Variations
Share to Epigenetics and DNA Methylation
Share to Testicular diseases and treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27936464
DOI: 10.18632/oncotarget.13811

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabinePMID 27936464Read ↗

Epigenetic treatment combinations to effectively target cisplatin‐resistant germ cell tumors: past, present, and future considerationsSemantic proximity Read ↗

Recent Advancements in Research on DNA Methylation and Testicular Germ Cell Tumors: Unveiling the Intricate RelationshipSemantic proximity Read ↗

Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapySemantic proximity Read ↗

Therapeutical interference with the epigenetic landscape of germ cell tumors: a comparative drug study and new mechanistical insightsSemantic proximity Read ↗

Epigenetic Remodeling through Downregulation of Polycomb Repressive Complex 2 Mediates Chemotherapy Resistance in Testicular Germ Cell TumorsSemantic proximity Read ↗

Epigenetic alterations as therapeutic targets in Testicular Germ Cell Tumours : current and future application of ‘epidrugs’Semantic proximity Read ↗

Between a Rock and a Hard Place: An Epigenetic-Centric View of Testicular Germ Cell TumorsSemantic proximity Read ↗

Mechanisms of cisplatin sensitivity and resistance in testicular germ cell tumorsSemantic proximity Read ↗

Targeting DNA Methyltranferases in Urological TumorsSemantic proximity Read ↗

Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6BSemantic proximity Read ↗

A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancerSemantic proximity Read ↗

Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6BSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.